Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[ 18 F]fluoro-2-deoxy- d -glucose (FDG) is a useful technique for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical o...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of radiology 2015-12, Vol.33 (12), p.776-789
Main Authors: Kitajima, Kazuhiro, Suenaga, Yuko, Sugimura, Kazuro
Format: Article
Language:English
Subjects:
Fluorodeoxyglucose F18
Head and Neck Neoplasms - diagnostic imaging
Humans
Imaging
Medicine
Medicine & Public Health
Multimodal Imaging - methods
Multimodal Imaging - trends
Nuclear Medicine
Positron-Emission Tomography - methods
Positron-Emission Tomography - trends
Radiology
Radiopharmaceuticals
Radiotherapy
Reproducibility of Results
Review
Tomography, X-Ray Computed - methods
Tomography, X-Ray Computed - trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Integrated positron emission tomography/computed tomography (PET/CT) with 2-[ 18 F]fluoro-2-deoxy- d -glucose (FDG) is a useful technique for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the initial staging, restaging, monitoring of the response to therapy, and prognostication of head and neck carcinoma. The present review discusses the current role of FDG-PET/CT in the management of head and neck carcinoma, focusing on its usefulness and limitations for imaging in these patients.
ISSN:1867-1071
1867-108X
DOI:10.1007/s11604-015-0495-1